Problem statement: Answer the multiple-choice question.
Query: Which compound exhibits a -16.709% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a) Cc1c(C(=O)Nc2ccccn2)sc2nc3n(c(=O)c12)CCC3
b) CNc1ncc(-c2nnnn2-c2ccccc2)c(-c2ccccc2)n1
c) C=CCn1c(SCC(=O)N(CCOC)c2c(N)n(CC(C)C)c(=O)[nH]c2=O)nc2ccccc21
Answer: b. CNc1ncc(-c2nnnn2-c2ccccc2)c(-c2ccccc2)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CNc1ncc(-c2nnnn2-c2ccccc2)c(-c2ccccc2)n1
CNc1ncc(-c2nnnn2-c2ccccc2)c(-c2ccccc2)n1
N-methyl-4-phenyl-5-(1-phenyltetrazol-5-yl)pyrimidin-2-amine